Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantRestricted Stock Unit · Derivative | 2,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-033202 · doc4.xml · derivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,743 Underlying: Common Stock · 2,743 shares Expires 2019-05-10 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
GrantStock Option (right to buy) · Derivative | 81,494 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033203 · doc4.xml · derivative · entry 2 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,494 Underlying: Common Stock · 81,494 shares Expires 2026-05-09 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantStock Option (right to buy) · Derivative | 101,868 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033204 · doc4.xml · derivative · entry 3 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,868 Underlying: Common Stock · 101,868 shares Expires 2026-05-09 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantStock Option (right to buy) · Derivative | 814,941 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033205 · doc4.xml · derivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 814,941 Underlying: Common Stock · 814,941 shares Expires 2026-05-09 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
GrantStock Option (right to buy) · Derivative | 54,329 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033206 · doc4.xml · derivative · entry 2 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,329 Underlying: Common Stock · 54,329 shares Expires 2026-05-09 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Golestani ClarkEVP & Chief Info Officer
|
GrantStock Option (right to buy) · Derivative | 50,934 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033207 · doc4.xml · derivative · entry 3 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,934 Underlying: Common Stock · 50,934 shares Expires 2026-05-09 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantStock Option (right to buy) · Derivative | 115,450 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033208 · doc4.xml · derivative · entry 2 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,450 Underlying: Common Stock · 115,450 shares Expires 2026-05-09 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Holston Michael JEVP, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 57,079 | $0.00 Strike: $44.28 | $0.00 |
DisclosureSEC source: 0001225208-16-033209 · doc4.xml · derivative · entry 6 Holston Michael J · CIK 0001390613 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,079 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 8/1/2013, 8/1/2014 and 8/1/2015. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Holston Michael JEVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 149,406 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033209 · doc4.xml · derivative · entry 5 Holston Michael J · CIK 0001390613 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,406 Underlying: Common Stock · 149,406 shares Expires 2026-05-09 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Holston Michael JEVP, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 42,942 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-16-033209 · doc4.xml · derivative · entry 4 Holston Michael J · CIK 0001390613 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,942 shares Expires 2023-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in equal installments on 5/6/2014, 5/6/2015 and 5/6/2016. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Holston Michael JEVP, General Counsel
|
SaleCommon Stock | 100,021 | $54.50 | $5,451,144.50 |
DisclosureSEC source: 0001225208-16-033209 · doc4.xml · nonDerivative · entry 3 Holston Michael J · CIK 0001390613 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,280.227 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Holston Michael JEVP, General Counsel
|
Exercise / conversionCommon Stock | 42,942 | $44.98 | $1,931,531.16 |
DisclosureSEC source: 0001225208-16-033209 · doc4.xml · nonDerivative · entry 2 Holston Michael J · CIK 0001390613 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,301.227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:39 UTC |
Holston Michael JEVP, General Counsel
|
Exercise / conversionCommon Stock | 57,079 | $44.28 | $2,527,458.12 |
DisclosureSEC source: 0001225208-16-033209 · doc4.xml · nonDerivative · entry 1 Holston Michael J · CIK 0001390613 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,359.227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:40 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantStock Option (right to buy) · Derivative | 40,747 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033210 · doc4.xml · derivative · entry 3 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,747 Underlying: Common Stock · 40,747 shares Expires 2026-05-09 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:40 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantRestricted Stock Unit · Derivative | 3,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-033210 · doc4.xml · derivative · entry 2 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,292 Underlying: Common Stock · 3,292 shares Expires 2019-05-10 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:40 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
GrantStock Option (right to buy) · Derivative | 271,647 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033211 · doc4.xml · derivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,647 Underlying: Common Stock · 271,647 shares Expires 2026-05-09 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:40 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantStock Option (right to buy) · Derivative | 50,934 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033212 · doc4.xml · derivative · entry 2 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,934 Underlying: Common Stock · 50,934 shares Expires 2026-05-09 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:40 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantStock Option (right to buy) · Derivative | 258,065 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033213 · doc4.xml · derivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,065 Underlying: Common Stock · 258,065 shares Expires 2026-05-09 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 10, 2016 Filed May 12, 2016 15:40 UTC |
Davis Robert MEVP, CFO & Global Svcs
|
GrantStock Option (right to buy) · Derivative | 251,273 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001225208-16-033214 · doc4.xml · derivative · entry 1 Davis Robert M · CIK 0001363076 · EVP, CFO & Global Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,273 Underlying: Common Stock · 251,273 shares Expires 2026-05-09 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:20 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,002 | $54.09 | $216,468.18 |
DisclosureSEC source: 0001225208-16-032903 · doc4.xml · derivative · entry 3 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,002 shares Expires 2016-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:20 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
Tax withholdingCommon Stock | 1,258 | $54.09 | $68,045.22 |
DisclosureSEC source: 0001225208-16-032903 · doc4.xml · nonDerivative · entry 2 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,171.795 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:20 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 4,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-032903 · doc4.xml · nonDerivative · entry 1 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,429.795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,002 | $54.09 | $216,468.18 |
DisclosureSEC source: 0001225208-16-032904 · doc4.xml · derivative · entry 3 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,002 shares Expires 2016-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Tax withholdingCommon Stock | 1,566 | $54.09 | $84,704.94 |
DisclosureSEC source: 0001225208-16-032904 · doc4.xml · nonDerivative · entry 2 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,654.646 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Exercise / conversionCommon Stock | 4,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-032904 · doc4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,220.646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,001 | $54.09 | $108,234.09 |
DisclosureSEC source: 0001225208-16-032905 · doc4.xml · derivative · entry 3 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,001 shares Expires 2016-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Tax withholdingCommon Stock | 746 | $54.09 | $40,351.14 |
DisclosureSEC source: 0001225208-16-032905 · doc4.xml · nonDerivative · entry 2 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,628.566 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionCommon Stock | 2,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-032905 · doc4.xml · nonDerivative · entry 1 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,374.566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
Exercise / conversionRestricted Stock Unit · Derivative | 44,464 | $54.09 | $2,405,057.76 |
DisclosureSEC source: 0001225208-16-032906 · doc4.xml · derivative · entry 3 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,464 shares Expires 2016-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
Tax withholdingCommon Stock | 26,946 | $54.09 | $1,457,509.14 |
DisclosureSEC source: 0001225208-16-032906 · doc4.xml · nonDerivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,953.392 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
Exercise / conversionCommon Stock | 44,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-032906 · doc4.xml · nonDerivative · entry 1 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,899.392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,335 | $54.09 | $180,390.15 |
DisclosureSEC source: 0001225208-16-032907 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,335 shares Expires 2016-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Tax withholdingCommon Stock | 1,243 | $54.09 | $67,233.87 |
DisclosureSEC source: 0001225208-16-032907 · doc4.xml · nonDerivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,685.178 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 06, 2016 Filed May 9, 2016 20:21 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionCommon Stock | 3,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-032907 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,928.178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 14, 2016 Filed Apr 14, 2016 18:25 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 131,040 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001225208-16-031436 · doc4.xml · derivative · entry 4 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 131,040 shares Expires 2017-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010. Read SEC document |
| April 14, 2016 Filed Apr 14, 2016 18:25 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 131,040 | $56.11 | $7,352,942.69 |
DisclosureSEC source: 0001225208-16-031436 · doc4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,477.063 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.0000 to $56.2300, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 14, 2016 Filed Apr 14, 2016 18:25 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 131,040 | $44.19 | $5,790,657.60 |
DisclosureSEC source: 0001225208-16-031436 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,517.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2016 Filed Apr 13, 2016 19:03 UTC |
HARRISON WILLIAM B JRDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.44 | $0.00 |
DisclosureSEC source: 0001225208-16-031395 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009. Read SEC document |
| April 13, 2016 Filed Apr 13, 2016 19:03 UTC |
HARRISON WILLIAM B JRDirector
|
Exercise / conversionCommon Stock | 5,000 | $34.44 | $172,200.00 |
DisclosureSEC source: 0001225208-16-031395 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2016 Filed Apr 4, 2016 20:02 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 614.2506 | $52.91 | $32,500.00 |
DisclosureSEC source: 0001225208-16-030773 · doc4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,209.517 Underlying: Common Stock · 614.2506 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2016 Filed Apr 4, 2016 20:02 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 756.0008 | $52.91 | $40,000.00 |
DisclosureSEC source: 0001225208-16-030774 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,601.9821 Underlying: Common Stock · 756.0008 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2016 Filed Apr 4, 2016 20:02 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 519.7505 | $52.91 | $27,500.00 |
DisclosureSEC source: 0001225208-16-030775 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,996.1485 Underlying: Common Stock · 519.7505 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2016 Filed Apr 4, 2016 20:02 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 567.0006 | $52.91 | $30,000.00 |
DisclosureSEC source: 0001225208-16-030776 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,310.1606 Underlying: Common Stock · 567.0006 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2016 Filed Apr 4, 2016 20:02 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 519.7505 | $52.91 | $27,500.00 |
DisclosureSEC source: 0001225208-16-030777 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,298.6475 Underlying: Common Stock · 519.7505 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 17:37 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantCommon Stock | 2,537 | $50.77 | $128,803.49 |
DisclosureSEC source: 0001225208-16-027756 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,408.122 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 17:37 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantCommon Stock | 14,557 | $50.77 | $739,058.89 |
DisclosureSEC source: 0001225208-16-027757 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,759.3521 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 17:37 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantCommon Stock | 11,332 | $50.77 | $575,325.64 |
DisclosureSEC source: 0001225208-16-027758 · doc4.xml · nonDerivative · entry 1 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,583.479 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 17:37 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantCommon Stock | 93,241 | $50.77 | $4,733,845.57 |
DisclosureSEC source: 0001225208-16-027759 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,477.063 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 17:37 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
GrantCommon Stock | 3,377 | $50.77 | $171,450.29 |
DisclosureSEC source: 0001225208-16-027760 · doc4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,986.088 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 17:38 UTC |
Golestani ClarkEVP & Chief Info Officer
|
GrantCommon Stock | 6,150 | $50.77 | $312,235.50 |
DisclosureSEC source: 0001225208-16-027761 · doc4.xml · nonDerivative · entry 1 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,313 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.